ctrl K

Watchlist Price Alert

Artiva Biotherapeutics In... (ARTV)

NASDAQ: ARTV · Real-Time Price · USD

1.96

-0.01 (-0.51%)

At close: Jun 05, 2025, 3:59 PM

1.97

0.69%

After-hours: Jun 05, 2025, 07:44 PM EDT

Artiva Biotherapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	251K	33.49M	4.93M	2M	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	251K	33.49M	4.93M	2M	n/a
Operating Income	-67.28M	-30.67M	-59.83M	-53.27M	-18.27M
Interest Income	5.35M	2.54M	1.29M	n/a	2K
Pretax Income	-58.49M	-27.62M	-58.34M	-71.83M	-17.99M
Net Income	-58.49M	-27.7M	-58.39M	-71.83M	-17.99M
Selling & General & Admin	17.2M	13.91M	20.78M	12.86M	4.43M
Research & Development	50.33M	50.25M	43.98M	42.41M	13.85M
Other Expenses	n/a	n/a	200K	-18.55M	477K
Operating Expenses	67.53M	64.16M	64.76M	55.27M	18.27M
Interest Expense	n/a	n/a	n/a	n/a	199K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	67.53M	64.16M	64.76M	55.27M	18.27M
Income Tax Expense	n/a	72K	53K	-18.55M	676K
Shares Outstanding (Basic)	11.26M	23.28M	17.58M	17.58M	17.58M
Shares Outstanding (Diluted)	11.26M	23.28M	17.58M	17.58M	17.58M
EPS (Basic)	-5.2	-1.19	-3.32	-4.08	-1.02
EPS (Diluted)	-5.2	-1.19	-3.32	-4.08	-1.02
EBITDA	-64.85M	-28.41M	-58.67M	-71.58M	-17.72M
EBIT	-67.28M	-30.67M	-59.83M	-71.83M	-17.59M
Depreciation & Amortization	2.43M	2.27M	1.16M	248K	73K